An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India

PLoS Neglected Tropical Diseases
Vittal MogasaleBinod Sah

Abstract

Service provider costs for vaccine delivery have been well documented; however, vaccine recipients' costs have drawn less attention. This research explores the private household out-of-pocket and opportunity costs incurred to receive free oral cholera vaccine during a mass vaccination campaign in rural Odisha, India. Following a government-driven oral cholera mass vaccination campaign targeting population over one year of age, a questionnaire-based cross-sectional survey was conducted to estimate private household costs among vaccine recipients. The questionnaire captured travel costs as well as time and wage loss for self and accompanying persons. The productivity loss was estimated using three methods: self-reported, government defined minimum daily wages and gross domestic product per capita in Odisha. On average, families were located 282.7 (SD = 254.5) meters from the nearest vaccination booths. Most family members either walked or bicycled to the vaccination sites and spent on average 26.5 minutes on travel and 15.7 minutes on waiting. Depending upon the methodology, the estimated productivity loss due to potential foregone income ranged from $0.15 to $0.29 per dose of cholera vaccine received. The private household cost ...Continue Reading

References

Sep 1, 1997·Social Science & Medicine·W K Asenso-Okyere, J A Dzator
Nov 4, 1993·PharmacoEconomics·M A Koopmanschap, F F Rutten
Nov 3, 2007·Pediatrics·Noëlle-Angélique M MolinariRichard A Schieber
Jul 29, 2010·International Journal of Health Geographics·Abdullah Al-TaiarChristopher J M Whitty
May 11, 2011·Epidemiology and Infection·C PoulosUNKNOWN DOMI Cholera COI Study Group
Jun 3, 2011·The American Journal of Tropical Medicine and Hygiene·Rita ReyburnMohammad Ali
Apr 18, 2012·BMJ : British Medical Journal·Nigel Hawkes
Jun 29, 2012·International Journal of Health Geographics·Justine I BlanfordAlan M MacEachren
Oct 31, 2012·Bulletin of the World Health Organization·Stephen MartinWilliam Perea
Jan 11, 2013·The New England Journal of Medicine·Ezra J BarzilayJordan W Tappero
Nov 6, 2013·BMC Infectious Diseases·Abdur Razzaque SarkerJahangir A M Khan
Oct 15, 2014·Transactions of the Royal Society of Tropical Medicine and Hygiene·M Ilaria PortaRony Zachariah
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Harashish JindalJagbir Singh Malik
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Shantanu K KarLinda M Kaljee
Aug 1, 2015·MMWR. Morbidity and Mortality Weekly Report·Sarah Reagan-SteinerShannon Stokley
Sep 4, 2015·MMWR. Morbidity and Mortality Weekly Report·Miwako KobayashiTamara Pilishvili
Nov 10, 2015·Vaccine·Christina R PharesPonchanok Rattanadilok Na Bhuket

❮ Previous
Next ❯

Citations

Apr 13, 2018·Human Vaccines & Immunotherapeutics·Samuel TeshomeVittal Mogasale
Sep 22, 2017·PloS One·Patrick G IlboudoJean-Bernard Le Gargasson

❮ Previous
Next ❯

Software Mentioned

R
ArcGIS Desktop
FoxPro

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved